Geno Germano

Mr. Geno J.
Germano is an Independent Chairman at Entera Bio Ltd. and an Independent Director at Precision BioSciences, Inc. He is on the Board of Directors at Eloxx Pharmaceuticals, Inc., Harmony Biosciences Holdings, Inc. and Precision BioSciences, Inc. Mr. Germano was previously employed as a President, Chief Executive Officer & Director by Elucida Oncology, Inc., an Independent Director by Bioverativ, Inc., a Chairman by SAGE Therapeutics, Inc., a President by Intrexon Corp., a Group President-Global Innovative Pharma Business by Pfizer Inc., a Trustee by Albany College of Pharmacy, a President & General Manager-Specialty Care by Wyeth LLC, a President-US Pharmaceuticals & Women's Health Care by Wyeth Pharmaceuticals LLC, a Member by Group of 50, a Managing Director by Wyeth Australia Pty Ltd., and a Managing Director by Wyeth New Zealand.
He also served on the board at Zoetis, Inc., Biotechnology Innovation Organization and The Medicines Co. He received his undergraduate degree from Albany College of Pharmacy & Health Sciences.